Adjunctive laser-stimulated stem-cells therapy to primary reperfusion in acute myocardial infarction in humans: Safety and feasibility study

Journal of Interventional Cardiology
Gabby Elbaz-GreenerAlex Blatt

Abstract

Low-level laser therapy (LLLT) has photobiostimulatory effects on stem cells and may offer cardioprotection. This cell-based therapy may compliment primary percutaneous coronary intervention (PPCI) in patients with ST-segment elevation myocardial infarction (STEMI). In this randomized control trial, our primary objective was to determine the safety and feasibility of LLLT application to the bone marrow in patients with STEMI undergoing PPCI. We randomly assigned patients undergoing PPCI to LLLT or non-laser therapy (NLT). In the LLLT group, 100 s of laser therapy was applied to the tibia bone prior to PPCI, as well as 24 and 72 h post-PPCI. In the control group, the power source was turned off. The primary outcome was the difference in door-to-balloon (D2B) time, and additional outcomes included differences in circulating cell counts, cardiac enzymes, and left-ventricular ejection fraction (LVEF) at pre-specified intervals post-PPCI. Twenty-four patients were randomized to LLLT (N = 12) or NLT (N = 12). No adverse effects of the treatment were detected. The D2B time was not significantly different between the groups (41 ± 8 vs 48 ± 1 min; P = 0.73). Creatinine Phosphokinase area under the curve, was lower after LLLT (22 ± 10) c...Continue Reading

References

Nov 1, 1989·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·P D BourdillonH Feigenbaum
Oct 22, 2008·Journal of Molecular and Cellular Cardiology·Rong ZhangMartin Bienengraeber
Apr 16, 2010·Science Translational Medicine·Christine L MummeryJose E Krieger
Jul 31, 2010·Circulation Research·Konstantinos E HatzistergosJoshua M Hare
May 20, 2011·Nature·Michael A Laflamme, Charles E Murry
Nov 16, 2011·JAMA : the Journal of the American Medical Association·Jay H TraverseUNKNOWN Cardiovascular Cell Therapy ResearchNetwork
Dec 15, 2012·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Aug 21, 2013·Circulation Research·Sang-Ging Ong, Joseph C Wu
Aug 6, 2014·Photomedicine and Laser Surgery·Brendan J QuirkHarry T Whelan
Feb 10, 2017·Circulation Research·Roberto Bolli

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.